Navigation Links
Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa
Date:11/8/2010

Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant... -- ABBOTT PARK, Ill., Nov. 8, 2010 /PRNewswire-FirstCall/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Biotechnology, Health Care & Hospitals, Infection Control, Medical Pharmaceuticals, Pharmaceuticals, Joint Ventures, Children-related News, Domestic Policy, Corporate Social Responsibility Click to view news release full screen  

Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa

 

ABBOTT PARK, Ill., Nov. 8, 2010 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) and the Clinton Health Access Initiative (CHAI) have joined forces to provide HIV testing to infants in all countries working in partnership with the CHAI.  A key focus of this cooperation will be sub-Saharan Africa, which the World Health Organization estimates to account for 90 percent of global HIV infections in children.

Under terms of the agreement, Abbott will supply its RealTime HIV-1 Qualitative test kits to healthcare facilities.  The test is currently available for research use only and is expected to be CE marked (Conformite Europeene) by January 2011.  Abbott will also offer the capability to collect and process samples using dried blood spots (DBS).  The use of DBS for specimen collection eliminates the need for refrigeration of specimens.

In addition to the supply of HIV tests and DBS sample collection for research use, Abbott is collaborating with CHAI to develop a "turn-key" laboratory solution, including training protocols on instruments that will be used to establish fully functioning molecular diagnostic laboratories in regions where such facilities do not currently exist.

"We're pleased to be collaborating with the CHAI in its proactive outreach effort to test infants in developing nations for HIV," said Stafford O'Kelly, head of Abbott's molecular diagnostics business.  "Accurate and accessible HIV testing, particularly for diagnosis of HIV/AIDS in infants less than 18 months of age, is essential for optimal management and treatment of the disease."

About Abbott Molecular Abbott Molecular, abbottmolecular.com, is an emerging leader in molecular diagnostics - the analysis of DNA, RNA, and proteins at the molecular level.  Abbott Molecular's instruments and assays are used for early detection and diagnosis of disease, to influence the selection of appropriate therapies and as an aid in monitoring disease progression.

About Abbott Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics.  The company employs nearly 90,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at www.abbott.com.


'/>"/>

SOURCE Abbott
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Abbott and Enanta Present Positive Initial Results from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
2. Abbott Again Recognized for Environmental Initiatives in Illinois
3. Abbott Statement: Abbott Provides Support for Cholera Relief Efforts in Haiti
4. Abbott to Voluntarily Withdraw Meridia® (Sibutramine) in the U.S.
5. Abbott Laboratories Agrees to Withdraw Its Obesity Drug Meridia
6. Abbott Named One of the Top Employers in the Biotech and Pharmaceutical Industry by Science Magazine
7. Abbott Receives FDA Market Clearance for Next-Generation Contact Lens Disinfecting Solution
8. Abbotts XIENCE V® Shows Continued Strong Performance in Key Safety and Efficacy Measures at Two Years in Investigator-Initiated COMPARE Trial
9. Abbott and Reata Pharmaceuticals Announce Agreement to Develop and Commercialize Bardoxolone Methyl for Chronic Kidney Disease Outside the U.S.
10. Abbotts Fully Bioresorbable Vascular Scaffold Technology Continues to Demonstrate Strong Clinical Results
11. The Deal Names Abbott Top Dealmaker for Third Consecutive Year
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... Colo. , Feb. 22, 2017  Aytu BioScience, ... global commercialization of novel products in the field of ... team to up to 42 account managers from 35 ... The sales force expansion is being ... prescriptions and revenues, an indication of increasing acceptance of ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 According ... (Spectroscopy, Chromatography), Measurement (On-Line, In-Line, At-Line), Products and Services (Analyzers, Probes & ... to 2021", published by MarketsandMarkets, the global market is poised to reach ... a CAGR of 13.3% from 2016 to 2021. ... ...
(Date:2/22/2017)... Feb. 22, 2017  CVS Pharmacy is the first ... partially hydrogenated oils (PHO), the primary source of artificial ... store brands food products. The retailer now offers over ... from artificial trans fats. This comes a year and a ... of June 2018 for processed foods to be reformulated ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... February 22, 2017 , ... ... the country today, as organizations, advocates, and individuals join together to increase recognition ... access to ultimately save lives. , “Today we mark a nationwide movement to ...
(Date:2/22/2017)... ... February 22, 2017 , ... Becker’s Spine Review, the ... featuring Michigan neurosurgeon Jay Jagannathan, M.D., as a “Spine Surgeon to Know.” ... neurosurgeons in Michigan performing minimally invasive back surgery that often results in less ...
(Date:2/22/2017)... ... February 22, 2017 , ... Michael J. ... media platform connecting healthcare technology professionals and other key stakeholders with an array ... publication starting on March 1, announced Michael J. Hennessy, Jr., president of MJH ...
(Date:2/22/2017)... ... 2017 , ... Super-Sod will attend the Athens Home Show with a brand ... shift from Super-Sod’s simple Athens Home Show booth of 2016, this year’s exhibit space ... manager Chris Roquemore constructed furniture from recycled pallet wood at the Super-Sod farm in ...
(Date:2/22/2017)... ... February 22, 2017 , ... ... who suffer from combat-related PTSD. , Established in 1977, our organization was at ... challenges of military returning to civilian life were evident and served as the ...
Breaking Medicine News(10 mins):